Travelers (NYSE: TRV) EVP sells 16,712 shares after exercising options

Rhea-AI Filing Summary

The Travelers Companies, Inc. executive Jeffrey P. Klenk, EVP & President of Bond & Specialty Insurance, reported option exercises and a share sale. On January 23, 2026, he exercised stock options for 4,912 shares at $140.85 and 11,800 shares at $132.58, receiving equivalent amounts of Travelers common stock.

On the same date, he sold 16,712 shares of common stock in a market transaction at a weighted average price of $279.7746, with individual trades ranging from $279.60 to $280.25. After these transactions, he directly owned 6,075.303 shares of common stock and 9,016 stock options.

Insider Trade Summary

Exercise and Sale: 16,712 shares ($2.42M approx. pre-tax spread)

Exercise and Sale 5 txns

Insider Klenk Jeffrey P.

Role EVP & Pres., Bond & Spec. Ins.

Sold 16,712 shs ($4.68M)

Approx. gross sale proceeds $4.68M

Approx. exercise cost $2.26M

Approx. pre-tax spread $2.42M

Type	Security	Shares	Price	Value
Exercise	Stock Options (Right to Buy)	4,912	$0.00	$0.00
Exercise	Stock Options (Right to Buy)	11,800	$0.00	$0.00
Exercise	Common Stock	4,912	$140.85	$692K
Exercise	Common Stock	11,800	$132.58	$1.56M
Sale	Common Stock	16,712	$279.7746	$4.68M

Holdings After Transaction: Stock Options (Right to Buy) — 9,016 shares (Direct); Common Stock — 6,075.303 shares (Direct)

Footnotes (1)

1. F1. Represents the weighted average sales price for increments ranging from $279.60 to $280.25. The Reporting Person undertakes to provide upon request by the Securities and Exchange Commission Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 01/26/2026 - 04:25 PM Learn about SEC filing dates

FAQ

What insider activity did TRV executive Jeffrey P. Klenk report?

Jeffrey P. Klenk, EVP & President of Bond & Specialty Insurance at The Travelers Companies, Inc. (TRV), reported exercising stock options and selling common shares on January 23, 2026.

How many Travelers (TRV) options did Jeffrey P. Klenk exercise?

On January 23, 2026, Jeffrey P. Klenk exercised stock options for 4,912 shares at $140.85 and 11,800 shares at $132.58, receiving the same number of Travelers common shares.

How many Travelers (TRV) shares did Jeffrey P. Klenk sell and at what price?

Jeffrey P. Klenk sold 16,712 shares of Travelers common stock at a weighted average price of $279.7746 per share, with individual sale prices between $279.60 and $280.25.

What are Jeffrey P. Klenk’s remaining Travelers (TRV) holdings after the transactions?

Following the reported transactions, Jeffrey P. Klenk directly owned 6,075.303 shares of Travelers common stock and 9,016 stock options (right to buy).

What do the transaction codes M and S mean in this TRV Form 4?

In this filing, code M indicates the exercise of stock options into common shares, and code S indicates an open-market sale of Travelers common stock.

What role does Jeffrey P. Klenk hold at The Travelers Companies, Inc. (TRV)?

Jeffrey P. Klenk is an Officer of The Travelers Companies, Inc., serving as EVP & President, Bond & Specialty Insurance.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Klenk Jeffrey P.

(Last) (First) (Middle)

THE TRAVELERS COMPANIES, INC.

385 WASHINGTON STREET

(Street)

ST. PAUL MN 55102

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
TRAVELERS COMPANIES, INC. [ TRV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP & Pres., Bond & Spec. Ins.

3. Date of Earliest Transaction (Month/Day/Year)
01/23/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/23/2026		M		4,912	A	$140.85	10,987.303	D
Common Stock	01/23/2026		M		11,800	A	$132.58	22,787.303	D
Common Stock	01/23/2026		S		16,712	D	$279.7746(1)	6,075.303	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options (Right to Buy)	$140.85	01/23/2026		M			4,912	02/06/2021	02/06/2028	Common Stock	4,912	$0	0	D
Stock Options (Right to Buy)	$132.58	01/23/2026		M			11,800	02/04/2023	02/04/2030	Common Stock	11,800	$0	9,016	D

Explanation of Responses:

1. Represents the weighted average sales price for increments ranging from $279.60 to $280.25. The Reporting Person undertakes to provide upon request by the Securities and Exchange Commission Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

	/s/Wendy C. Skjerven, by power of attorney	01/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.